This observation suggests that by downregulating CCNA1 we obtain a shift of the transcriptomic signature associated with aggressive OSCC tumours towards that of the less aggressive forms of OSCC, and therefore that CCNA1 could be a good target for therapeutic approaches in 3-genes positive tumours. The gene discussed is CCNA1; the disease is neoplasm.